Start Date
May 31, 2003
Study Completion Date
February 28, 2011
bevacizumab
capecitabine
fluorouracil
leucovorin calcium
oxaliplatin
St. Vincents Comprehensive Cancer Center, New York
New York University Medical Center, New York
Advanced Oncology Associates, Armonk
New York Medical College, Valhalla
Arena Oncology Associates, Great Neck
North Shore Hematology/Oncology Associates, P.C., East Setauket
Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh
Pennsylvania Oncology Hematology Associates, Philadelphia
Lombardi Cancer Center at Georgetown University Medical Center, Washington D.C.
Greater Baltimore Medical Center and Cancer Center, Baltimore
Southeastern Medical Oncology Center, Goldsboro
Duke Comprehensive Cancer Center, Durham
Physicians East - Quadrangle, Greenville
Charleston Hematology-Oncology, P.A., Charleston
Peachtree Hematology and Oncology Consultants, P.C., Atlanta
Florida Oncology Associates, Jacksonville
Hematology and Oncology Consultants, P.A., Orlando
Palm Beach Cancer Institute, West Palm Beach
Lynn Regional Cancer Center West, Boca Raton
Florida Cancer Specialists, Fort Myers
Hematology Oncology Associates of theTreasure Coast - Port St. Lucie, Port Saint Lucie
Sarah Cannon Cancer Center at Centennial Medical Center, Nashville
McCleod Cancer and Blood Center, Johnson City
Memphis Cancer Center, Memphis
West Clinic, Memphis
Jackson Oncology Associates, PLLC, Jackson
Hematology Oncology Consultants Inc, Columbus
CCOP - Northern Indiana CR Consortium, South Bend
West Suburban Center for Cancer Care, River Forest
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago
Saint Anthony Medical Center, Rockford
Veterans Affairs Medical Center - Kansas City, Kansas City
Medical City Dallas Hospital, Dallas
Center for Cancer Prevention and Care at Scott and White Clinic, Temple
South Texas Oncology and Hematology, San Antonio
Lone Star Oncology, Austin
Rocky Mountain Cancer Centers - Midtown, Denver
North Idaho Cancer Center, Coeur d'Alene
Arizona Clinical Research Center, Tucson
Cancer and Blood Institute of the Desert, Rancho Mirage
Valley Tumor Medical Group, Lancaster
Hematology/Oncology of Salem, Salem
University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham
California Cancer Care, Inc., Greenbrae
Northwestern Connecticut Oncology-Hematology Associates, Torrington
Lutheran General Cancer Care Center, Park Ridge
Cedar Rapids Oncology Associates, Cedar Rapids
CCOP - Wichita, Wichita
Deaconess Billings Clinic Cancer Center, Billings
Cooper Cancer Institute at Cooper University Hospital, Voorhees Township
Raleigh Hematology/Oncology Associates, P.A. - Wake Practice, Raleigh
Medical Consultants, Milwaukee
Prologue Research International
INDUSTRY